1
|
Cardona F, Castellano-Castillo D, Ramos-Molina B, Martínez-Sanchez M, Frutos-Bernal M, Queipo-Ortuño M. Chromatin configuration is altered in NASH resulting in deleterious rna expression related to NASH etiology. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
2
|
Clemente F, Matassini C, Faggi C, Giachetti S, Cresti C, Morrone A, Paoli P, Goti A, Martínez-Bailén M, Cardona F. Glucocerebrosidase (GCase) activity modulation by 2-alkyl trihydroxypiperidines: Inhibition and pharmacological chaperoning. Bioorg Chem 2020; 98:103740. [PMID: 32200326 DOI: 10.1016/j.bioorg.2020.103740] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2019] [Revised: 02/26/2020] [Accepted: 03/07/2020] [Indexed: 12/22/2022]
Abstract
The enzyme glucocerebrosidase (GCase) has become an important therapeutic target due to its involvement in pathological disorders consequent to enzyme deficiency, such as the lysosomal storage Gaucher disease (GD) and the neurological Parkinson disease (PD). Pharmacological chaperones (PCs) are small compounds able to stabilize enzymes when used at sub-inhibitory concentrations, thus rescuing enzyme activity. We report the stereodivergent synthesis of trihydroxypiperidines alkylated at C-2 with both configurations, by means of the stereoselective addition of Grignard reagents to a carbohydrate-derived nitrone in the presence or absence of Lewis acids. All the target compounds behave as good GCase inhibitors, with IC50 in the micromolar range. Moreover, compound 11a behaves as a PC in fibroblasts derived from Gaucher patients bearing the N370/RecNcil mutation and the homozygous L444P mutation, rescuing the activity of the deficient enzyme by up to 1.9- and 1.8-fold, respectively. Rescues of 1.2-1.4-fold were also observed in wild-type fibroblasts, which is important for targeting sporadic forms of PD.
Collapse
Affiliation(s)
- F Clemente
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino (FI), Italy
| | - C Matassini
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino (FI), Italy.
| | - C Faggi
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino (FI), Italy
| | - S Giachetti
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino (FI), Italy
| | - C Cresti
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino (FI), Italy
| | - A Morrone
- Paediatric Neurology Unit and Laboratories, Neuroscience Department, Meyer Children's Hospital, and Department of Neurosciences, Pharmacology and Child Health, University of Florence, Viale Pieraccini n. 24, 50139 Firenze, Italy
| | - P Paoli
- Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy
| | - A Goti
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino (FI), Italy; Associated with Consorzio Interuniversitario Nazionale di ricerca in Metodologie e Processi Innovativi di Sintesi (CINMPIS), Italy
| | - M Martínez-Bailén
- Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, c/ Prof. García González 1, E-41012 Sevilla, Spain
| | - F Cardona
- Department of Chemistry 'Ugo Schiff', University of Firenze, via della Lastruccia 3-13, 50019 Sesto Fiorentino (FI), Italy; Associated with Consorzio Interuniversitario Nazionale di ricerca in Metodologie e Processi Innovativi di Sintesi (CINMPIS), Italy.
| |
Collapse
|
3
|
Eguia A, Bagán-Debón L, Cardona F. Review and update on drugs related to the development of osteonecrosis of the jaw. Med Oral Patol Oral Cir Bucal 2020; 25:e71-e83. [PMID: 31880288 PMCID: PMC6982985 DOI: 10.4317/medoral.23191] [Citation(s) in RCA: 41] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2019] [Accepted: 07/07/2019] [Indexed: 02/07/2023] Open
Abstract
Background Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious adverse effect of certain drugs, of which bisphosphonates are the most widely known. This pathology is also associated with other medications such as the biologic antiresorptive agent, denosumab and some antiangiogenics such as sunitinib, bevacizumab or aflibercept. Very recently, new medications have also been associated with osteonecrosis of the jaw (ONJ). The objectives were to update the list of medications associated with ONJ, to analyze the fundamental aspects of this list and to describe the level of evidence available.
Material and Methods A narrative bibliographic review was made, using the PubMed-MedLine, DOAJ and SCIELO databases. Additional information was obtained through the online Medication Information Centre of the Spanish Agency of Medicines and Medical Devices (AEMPS – CIMA), the websites of the US Food & Drugs Administration (Drugs@FDA) and the European Medicines Agency (EMA).
Results The latest drugs identified as potential facilitators of this pathology include a number of anti-VEGF based antiangiogenic drugs and anti-TKI and different types of immunomodulators. Neither the level of evidence in this association nor the risk are equal for all these drugs. On the other hand, over the coming years, new drugs will be marketed with similar action mechanisms to those that are recognized as having this adverse effect.
Conclusions No effective therapy is currently known for the treatment of ONJ. Therefore, in order to prevent new cases of MRONJ, it is essential for all oral healthcare professionals to be fully up-to-date with the etiopathogenic aspects of this pathology and to be aware of those drugs considered to be a risk. Key words:Osteonecrosis of the jaw, MRONJ, bisphosphonates, antiresorptives, antiangiogenics.
Collapse
Affiliation(s)
- A Eguia
- Departamento de Inmunología, Microbiología y Parasitología Facultad de Medicina y Enfermería Universidad del País Vasco/Euskal Herriko Unibertsitatea UPV/EHU Apartado 699, 48080 Bilbao, Spain
| | | | | |
Collapse
|
4
|
Baglioni V, Coutinho E, Menassa DA, Giannoccaro MP, Jacobson L, Buttiglione M, Petruzzelli O, Cardona F, Vincent A. Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort. Brain Behav Immun 2019; 81:665-669. [PMID: 31425826 DOI: 10.1016/j.bbi.2019.08.008] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/27/2019] [Revised: 08/12/2019] [Accepted: 08/14/2019] [Indexed: 10/26/2022] Open
Abstract
In Tourette Syndrome (TS) a role for autoantibodies directed against neuronal proteins has long been suspected, but so far results are still inconsistent. The aim of this study was to look for antibodies to specific or undefined neuronal proteins that could be involved in the aetiology of the disease. Sera from children with Tourette Syndrome or another chronic tic disorder (TS/TD), collected as part of the longitudinal European Multicenter Tics in Children Study, were investigated. Participants included 30 siblings of patients with TS/TD prior to developing tics (preclinical stage) and the same children after the first tic onset (onset), and 158 patients in the chronic phase undergoing an acute relapse (exacerbation). Presence of antibodies binding to rodent brain tissue was assessed by immunohistology on rat brain sections and by immunofluorescent staining of live hippocampal neurons. Live cell-based assays were used to screen for antibodies to NMDAR, CASPR2, LGI1, AMPAR and GABAAR. Immunohistology indicated evidence of antibodies reactive with brain tissue, binding mainly to the hippocampus, the basal ganglia or the cerebellum in 26/218 (12%), with 8% of the preclinical or onset sera binding to the dentate gyrus/CA3 region or cerebellum. Only two individuals (one pre-clinical, one chronic) had antibodies binding the NMDAR and the binding was only weakly positive. No other specific antibodies were detected. Despite some immunoreactivity towards neuronal antigens on brain tissue, this was not mirrored by antibodies binding to live neurons, suggesting the presence of non-specific antibodies or those that bind non-pathogenic intracellular epitopes. NMDAR or the other neuronal surface antibodies tested were very infrequent in these patients. The evidence for pathogenic antibodies that could be causative of TS is weak.
Collapse
Affiliation(s)
- V Baglioni
- Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK; Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy
| | - E Coutinho
- Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
| | - D A Menassa
- Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
| | - M P Giannoccaro
- Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
| | - L Jacobson
- Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
| | - M Buttiglione
- Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy
| | - O Petruzzelli
- Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy
| | - F Cardona
- Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy
| | - A Vincent
- Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
| | | |
Collapse
|
5
|
Giordano V, Deindl P, Fuiko R, Unterasinger L, Waldhoer T, Cardona F, Berger A, Olischar M. Effect of increased opiate exposure on three years neurodevelopmental outcome in extremely preterm infants. Early Hum Dev 2018; 123:1-5. [PMID: 29935388 DOI: 10.1016/j.earlhumdev.2018.06.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2018] [Revised: 06/07/2018] [Accepted: 06/12/2018] [Indexed: 10/28/2022]
Abstract
BACKGROUND International guidelines recommend the use of item based scales for the assessment of pain and sedation. In our previous study, the implementation of the Neonatal Pain Agitation and Sedation Scale (N-PASS), and the associated systematic assessment and treatment of pain and sedation reduced pain and over-sedation in our intervention group, but lead to a significant increase of individual opiate exposure. This increased opiate exposure was not associated with impaired motor and mental development at one year of age. As one-year follow-up is not necessarily representative for future outcomes, we retested our sample at three years of age. METHODS Fifty-three patients after (intervention group) and 61 before implementation (control group) of the N-PASS and the Vienna Protocol for the Management of Neonatal Pain and Sedation (VPNPS), were compared for motor, mental and behavioural development at three-years follow-up using the Bayley Scales of Infant Development. RESULTS Cumulative opiate exposure was not associated with mental (p = .31) and motor (p = .20) problems when controlling for other important medical conditions, but was associated to lower behavioural scores (p = .007). No statistically significant differences were found with regard to mental (p = .65), psychomotor (p = .12) and behavioural (p = .61) development before and after the implementation of the N-PASS and the VPNPS. CONCLUSION Implementing a neonatal pain and sedation protocol increased opiate exposure without affecting neurodevelopmental outcome at three-years of age.
Collapse
Affiliation(s)
- V Giordano
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Austria.
| | - P Deindl
- Department of Neonatology and Pediatric Intensive Care Medicine, University Children's Hospital, University Medical Center Hamburg Eppendorf, Germany
| | - R Fuiko
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Austria
| | - L Unterasinger
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Austria
| | - T Waldhoer
- Department of Epidemiology, Center for Public Health, Medical University of Vienna, Austria
| | - F Cardona
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Austria
| | - A Berger
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Austria
| | - M Olischar
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Austria
| |
Collapse
|
6
|
Matassini C, Vanni C, Goti A, Morrone A, Marradi M, Cardona F. Multimerization of DAB-1 onto Au GNPs affords new potent and selective N-acetylgalactosamine-6-sulfatase (GALNS) inhibitors. Org Biomol Chem 2018; 16:8604-8612. [DOI: 10.1039/c8ob02587h] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Gold glyconanoparticles (Au GNPs) decorated with the natural iminosugar DAB-1 at different densities are reported.
Collapse
Affiliation(s)
- C. Matassini
- Department of Chemistry ‘Ugo Schiff’
- University of Firenze
- Sesto Fiorentino
- Italy
- Associated with CNR-INO and LENS
| | - C. Vanni
- Department of Chemistry ‘Ugo Schiff’
- University of Firenze
- Sesto Fiorentino
- Italy
| | - A. Goti
- Department of Chemistry ‘Ugo Schiff’
- University of Firenze
- Sesto Fiorentino
- Italy
- Associated with CNR-INO and LENS
| | - A. Morrone
- Paediatric Neurology Unit and Laboratories
- Neuroscience Department
- Meyer Children's Hospital
- and Department of Neurosciences
- Pharmacology and Child Health
| | - M. Marradi
- CIC biomaGUNE and CIBER-BBN
- Donostia-San Sebastián
- Spain
| | - F. Cardona
- Department of Chemistry ‘Ugo Schiff’
- University of Firenze
- Sesto Fiorentino
- Italy
- Associated with CNR-INO and LENS
| |
Collapse
|
7
|
Moreno-Indias I, Tinahones FJ, Clemente-Postigo M, Castellano-Castillo D, Fernández-García JC, Macias-Gonzalez M, Queipo-Ortuño MI, Cardona F. Molecular effect of fenofibrate on PBMC gene transcription related to lipid metabolism in patients with metabolic syndrome. Clin Endocrinol (Oxf) 2017; 86:784-790. [PMID: 28251701 DOI: 10.1111/cen.13320] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Revised: 02/08/2017] [Accepted: 02/25/2017] [Indexed: 01/21/2023]
Abstract
BACKGROUND Both fasting and postprandial hypertriglyceridaemia are considered independent risk factors for atherosclerosis. Treatment of hypertriglyceridaemia is based on fibrates, which activate the peroxisome proliferator-activated receptor alpha (PPARα). However, the metabolic pathways that activate or inhibit fibrates, and how the postprandial triglyceride levels are modified, have not yet been fully described. Accordingly, the aim of this study was to determine the feasibility of peripheral blood mononuclear cells (PBMC) to study the effects of fenofibrate in patients with the metabolic syndrome. MATERIALS AND METHODS A fat overload was given to 50 patients before and after treatment with fenofibrate for 3 months. Anthropometric and biochemical variables as well as gene expression in PBMC were analysed. RESULTS After treatment with fenofibrate, we observed a decrease in both baseline and postprandial (3 h after the fat overload) levels of serum triglycerides, cholesterol and uric acid and an increase in HDL cholesterol and apolipoprotein AI levels. After treatment, there was also a rise in PPARα and RXRα expression and changes in genes regulated by PPARα, both baseline and postprandial. Furthermore, in vitro experiments showed that a PPARα agonist changed the expression of genes related with lipid metabolism. CONCLUSION Treatment with fenofibrate reduced fasting and postprandial serum triglyceride levels, possibly through a mechanism related with an increase in the expression of RXRα and PPARα, by activating the pathways involved in the uptake and degradation of triglycerides and increasing the synthesis of apolipoprotein. These results suggest that PBMC may be useful for the easy study of fenofibrate actions.
Collapse
Affiliation(s)
- I Moreno-Indias
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Spain
- Unidad Gestión Clínica Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain
- Hospital Clinico Universitario Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
| | - F J Tinahones
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Spain
- Unidad Gestión Clínica Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain
- Hospital Clinico Universitario Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
| | - M Clemente-Postigo
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Spain
- Unidad Gestión Clínica Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain
- Hospital Clinico Universitario Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
| | - D Castellano-Castillo
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Spain
- Unidad Gestión Clínica Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain
- Hospital Clinico Universitario Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
| | - J C Fernández-García
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Spain
- Unidad Gestión Clínica Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain
- Hospital Clinico Universitario Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
| | - M Macias-Gonzalez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Spain
- Unidad Gestión Clínica Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain
- Hospital Clinico Universitario Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
| | - M I Queipo-Ortuño
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Spain
- Unidad Gestión Clínica Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain
- Hospital Clinico Universitario Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
| | - F Cardona
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Spain
- Unidad Gestión Clínica Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain
- Hospital Clinico Universitario Virgen de la Victoria, Universidad de Malaga, Malaga, Spain
| |
Collapse
|
8
|
Cardona F, Pérez-Tur J. Proteomic Alterations by Mutations Involved in Parkinson's Disease and Related Disorders. Curr Protein Pept Sci 2017; 18:654-655. [DOI: 10.2174/138920371807170508185242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- F. Cardona
- Instituto de Biomedicina de Valencia Consejo Superior de Investigaciones Científicas (IBV-CSIC) Calle Jaime Roig 11 Valencia E46010, Spain
| | - J. Pérez-Tur
- Instituto de Biomedicina de Valencia Consejo Superior de Investigaciones Científicas (IBV-CSIC) Calle Jaime Roig 11 Valencia E46010, Spain
| |
Collapse
|
9
|
Mirabella S, Fibbi G, Matassini C, Faggi C, Goti A, Cardona F. Accessing 2-substituted piperidine iminosugars by organometallic addition/intramolecular reductive amination: aldehyde vs. nitrone route. Org Biomol Chem 2017; 15:9121-9126. [DOI: 10.1039/c7ob01848g] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
A novel dual strategy to build 2-substituted trihydroxypiperidines.
Collapse
Affiliation(s)
- S. Mirabella
- Department of Chemistry “Ugo Schiff”
- University of Firenze
- 50019 Sesto Fiorentino (FI)
- Italy
| | - G. Fibbi
- Department of Chemistry “Ugo Schiff”
- University of Firenze
- 50019 Sesto Fiorentino (FI)
- Italy
| | - C. Matassini
- Department of Chemistry “Ugo Schiff”
- University of Firenze
- 50019 Sesto Fiorentino (FI)
- Italy
- Associated with CNR-INO
| | - C. Faggi
- Department of Chemistry “Ugo Schiff”
- University of Firenze
- 50019 Sesto Fiorentino (FI)
- Italy
| | - A. Goti
- Department of Chemistry “Ugo Schiff”
- University of Firenze
- 50019 Sesto Fiorentino (FI)
- Italy
- Associated with CNR-INO
| | - F. Cardona
- Department of Chemistry “Ugo Schiff”
- University of Firenze
- 50019 Sesto Fiorentino (FI)
- Italy
- Associated with CNR-INO
| |
Collapse
|
10
|
Marsili L, Suppa A, Di Stasio F, Belvisi D, Upadhyay N, Berardelli I, Pasquini M, Petrucci S, Ginevrino M, Fabbrini G, Cardona F, Defazio G, Berardelli A. BDNF and LTP-/LTD-like plasticity of the primary motor cortex in Gilles de la Tourette syndrome. Exp Brain Res 2016; 235:841-850. [DOI: 10.1007/s00221-016-4847-6] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2016] [Accepted: 11/24/2016] [Indexed: 01/13/2023]
|
11
|
Macerollo A, Martino D, Cavanna AE, Gulisano M, Hartmann A, Hoekstra PJ, Hedderly T, Debes NM, Muller-Vahl K, Neuner I, Porta M, Rickards H, Rizzo R, Cardona F, Roessner V. Refractoriness to pharmacological treatment for tics: A multicentre European audit. J Neurol Sci 2016; 366:136-138. [PMID: 27288792 DOI: 10.1016/j.jns.2016.05.004] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2015] [Revised: 04/05/2016] [Accepted: 05/02/2016] [Indexed: 11/17/2022]
Affiliation(s)
- A Macerollo
- Sobell Department of Motor Neuroscience and Movement Disorders, The National Hospital of Neurology and Neurosurgery, Institute of Neurology, University College London, London, United Kingdom
| | - D Martino
- International Parkinson's Centre of Excellence, King's College and King's College Hospital, Denmark Hill Campus, London, United Kingdom; Queen Elizabeth Hospital, Woolwich, Lewisham & Greenwich NHS Trust, London, United Kingdom.
| | - A E Cavanna
- Department of Neuropsychiatry, BSMHFT and University of Birmingham, United Kingdom
| | - M Gulisano
- Section of Child Neuropsichiatry, Dipartimento di Scienze Mediche e Pediatriche, Catania University, Catania, Italy
| | - A Hartmann
- Centre de Référence National Maladie Rare: Syndrome Gilles de la Tourette, Département de Neurologie, Pôle des Maladies du Système Nerveux, France
| | - P J Hoekstra
- Department of Child and Adolescent Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - T Hedderly
- TANDeM Clinic-Evelina London Children's Hospital at Guys and St. Thomas', Kings Health Partners AHSC, London, United Kingdom
| | - N M Debes
- Pediatric Department, Glostrup University Hospital, Glostrup, Denmark
| | - K Muller-Vahl
- Clinic of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Street 1, D-30625 Hannover, Germany
| | - I Neuner
- Institute of Neuroscience and Medicine 4, (INM 4), Forschungszentrum, Jülich, Jülich, Germany; Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, JARA-BRAIN - Translational Medicine, Germany
| | - M Porta
- Departments of Neurosurgery and Neurology, IRCCS Galeazzi, Milan, Italy
| | - H Rickards
- Department of Neuropsychiatry, BSMHFT and University of Birmingham, United Kingdom
| | - R Rizzo
- Section of Child Neuropsichiatry, Dipartimento di Scienze Mediche e Pediatriche, Catania University, Catania, Italy
| | - F Cardona
- Department of Psychology, University of Rome, La Sapienza, Rome, Italy
| | - V Roessner
- Klinik und Poliklinikfür Kinder- und Jugendpsychiatrie und -psychotherapie, TechnischeUniversität Dresden, Germany
| |
Collapse
|
12
|
D'Adamio G, Matassini C, Parmeggiani C, Catarzi S, Morrone A, Goti A, Paoli P, Cardona F. Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs). RSC Adv 2016. [DOI: 10.1039/c6ra15806d] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
New targets sensitive to multivalency: synthesis of nonavalent pyrrolidine iminosugars.
Collapse
Affiliation(s)
- G. D'Adamio
- Department of Chemistry “Ugo Schiff”
- University of Florence
- 50019 Sesto Fiorentino
- Italy
| | - C. Matassini
- Department of Chemistry “Ugo Schiff”
- University of Florence
- 50019 Sesto Fiorentino
- Italy
| | - C. Parmeggiani
- Department of Chemistry “Ugo Schiff”
- University of Florence
- 50019 Sesto Fiorentino
- Italy
- CNR – INO and LENS
| | - S. Catarzi
- Paediatric Neurology Unit and Laboratories
- Neuroscience Department
- Meyer Children's Hospital
- Department of Neurosciences
- Pharmacology and Child Health
| | - A. Morrone
- Paediatric Neurology Unit and Laboratories
- Neuroscience Department
- Meyer Children's Hospital
- Department of Neurosciences
- Pharmacology and Child Health
| | - A. Goti
- Department of Chemistry “Ugo Schiff”
- University of Florence
- 50019 Sesto Fiorentino
- Italy
| | - P. Paoli
- Department of Experimental and Clinical Biomedical Sciences
- University of Florence
- 50134 Florence
- Italy
| | - F. Cardona
- Department of Chemistry “Ugo Schiff”
- University of Florence
- 50019 Sesto Fiorentino
- Italy
| |
Collapse
|
13
|
Mirabella S, Cardona F, Goti A. From glycals to aminosugars: a challenging test for new stereoselective aminohydroxylation and related methodologies. Org Biomol Chem 2016; 14:5186-204. [DOI: 10.1039/c6ob00649c] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
The most relevant methods to access 1-, 2-, 3-amino or 1,2-diaminosugars starting from unsaturated carbohydrates are concisely reviewed; the given examples illustrate the great challenges offered to several stereoselective strategies.
Collapse
Affiliation(s)
- S. Mirabella
- Dipartimento di Chimica “Ugo Schiff”
- Università degli Studi di Firenze
- Sesto Fiorentino (FI)
- Italy
| | - F. Cardona
- Dipartimento di Chimica “Ugo Schiff”
- Università degli Studi di Firenze
- Sesto Fiorentino (FI)
- Italy
| | - A. Goti
- Dipartimento di Chimica “Ugo Schiff”
- Università degli Studi di Firenze
- Sesto Fiorentino (FI)
- Italy
- ICCOM-CNR
| |
Collapse
|
14
|
Surendran R, Clemente-Postigo M, Kootte R, van Eijk M, Garrido-Sanchez L, Cardona F, Tinahones F, Nieuwdorp M, Dallinga-Thie G. Impaired insulin signalling leads to decreased expression of GPIHBP1. Atherosclerosis 2015. [DOI: 10.1016/j.atherosclerosis.2015.04.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
15
|
Maison P, Picot C, Courné M, de Haro L, Cardona F. Veille et sécurité sanitaire des toxiques – implication des agences sanitaires – Agence nationale de sécurité du médicament et des produits de santé (ANSM). Toxicologie Analytique et Clinique 2015. [DOI: 10.1016/j.toxac.2015.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
16
|
Gerstl N, Youssef C, Cardona F, Klebermass-Schrehof K, Grill A, Weninger M, Berger A, Olischar M. Management of hypothermia for perinatal asphyxia in Austria - a survey of current practice standards. Klin Padiatr 2015; 227:10-4. [PMID: 25565193 DOI: 10.1055/s-0034-1377036] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
BACKGROUND Therapeutic hypothermia (HT) has been shown to reduce the risk of death or disability and increase the rate of survival free of -disability at 18-24 months of age in hypoxic-ischemic encephalopathy (HIE). OBJECTIVES The aim of this study was to take a national survey which (a) evaluated the practice of therapeutic HT for perinatal asphyxia in Austria, (b) evaluated the current clinical management of neonatal HIE and (c) evaluated the need for a national perinatal asphyxia and HT registry. METHODS In January 2013, a questionnaire was sent out to the clinical heads of all neonatal level-II and level-III units in Austria. RESULTS We received replies from all 30 level II and level III units in Austria (response rate 100%). 19 units (63%) answered that they applied HT, 11 units (37%) said they transferred patients for cooling to other units, 3 of those 11 units (27%) said they applied cooling during transport. 25 units (83%) felt the necessity to establish a national registry. CONCLUSION The results of this survey show that there is already a high implementation of therapeutic HT in Austria, but there remains a need for information, awareness and training. Problem areas tend to be in the transport of asphyxiated neonates, brain monitoring during cooling and follow-up of affected patients. We believe, that the establishment of national guidelines and a national register could increase awareness for the importance of therapeutic HT in neonatal HIE, thus improve the Austrian management of those infants.
Collapse
Affiliation(s)
- N Gerstl
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - C Youssef
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - F Cardona
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - K Klebermass-Schrehof
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - A Grill
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - M Weninger
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - A Berger
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - M Olischar
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| |
Collapse
|
17
|
Matassini C, Marradi M, Cardona F, Parmeggiani C, Robina I, Moreno-Vargas AJ, Penadés S, Goti A. Gold nanoparticles are suitable cores for building tunable iminosugar multivalency. RSC Adv 2015. [DOI: 10.1039/c5ra22152h] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Inhibition in the low micromolar range towards amyloglucosidase.
Collapse
Affiliation(s)
- C. Matassini
- Dipartimento di Chimica “Ugo Schiff”
- Università di Firenze
- 50019 Sesto Fiorentino
- Italy
- CIC biomaGUNE
| | - M. Marradi
- CIC biomaGUNE
- Biofunctional Nanomaterials Unit
- Lab. GlycoNanoTechnology
- San Sebastián
- Spain
| | - F. Cardona
- Dipartimento di Chimica “Ugo Schiff”
- Università di Firenze
- 50019 Sesto Fiorentino
- Italy
| | - C. Parmeggiani
- Dipartimento di Chimica “Ugo Schiff”
- Università di Firenze
- 50019 Sesto Fiorentino
- Italy
- CNR – INO and LENS
| | - I. Robina
- Departamento de Química Orgánica
- Facultad de Química
- Universidad de Sevilla
- Sevilla
- Spain
| | - A. J. Moreno-Vargas
- Departamento de Química Orgánica
- Facultad de Química
- Universidad de Sevilla
- Sevilla
- Spain
| | - S. Penadés
- CIC biomaGUNE
- Biofunctional Nanomaterials Unit
- Lab. GlycoNanoTechnology
- San Sebastián
- Spain
| | - A. Goti
- Dipartimento di Chimica “Ugo Schiff”
- Università di Firenze
- 50019 Sesto Fiorentino
- Italy
| |
Collapse
|
18
|
Gerstl N, Youssef C, Cardona F, Klebermass-Schrehof K, Grill A, Weninger M, Berger A, Olischar M. Correction: Management of Hypothermia for Perinatal Asphyxia in Austria – a Survey of Current Practice Standards. Klin Padiatr 2015; 227:e1. [DOI: 10.1055/s-0035-1548804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- N. Gerstl
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - C. Youssef
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - F. Cardona
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - K. Klebermass-Schrehof
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - A. Grill
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - M. Weninger
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - A. Berger
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| | - M. Olischar
- Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria
| |
Collapse
|
19
|
Castellano-Castillo D, Moreno-Indias I, Picon-Cesar M, Garcia-Aleman J, Macias-Gonzalez M, Tinahones F, Queipo Ortuño M, Cardona F. Asociation between metabolic status and the methylation level of genes involved in metabolic disorders and obesity. Atherosclerosis 2014. [DOI: 10.1016/j.atherosclerosis.2014.05.356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
20
|
Repa A, Mayerhofer M, Worel N, Cardona F, Deindl P, Pollak A, Berger A, Haiden N. Blood transfusions using 27 gauge PICC lines: a retrospective clinical study on safety and feasibility. Klin Padiatr 2014; 226:3-7. [PMID: 24435791 DOI: 10.1055/s-0033-1363244] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND Blood transfusions are required by most extremely low birth weight (ELBW) infants, but sometimes an adequate peripheral venous access cannot be achieved. Under these circumstances, we used 27 Gauge (G) peripherally inserted central catheter (PICC) lines that are routinely inserted on the second day of life. Due to their narrow lumen, hemolysis of transfused erythrocytes was a major concern. We therefore performed a retrospective study in ELBW infants to analyze the incidence, safety and feasibility of PRBC transfusions via 27 G PICC lines. METHODS ELBW infants admitted from 08/2011-07/2012 were screened for packed red blood cell (PRBC) transfusions. Those applied via 27 G PICC lines were identified. For analysis of transfusion safety (hemolysis), hemoglobin and potassium levels as well as cardiovascular variables (invasive mean arterial blood pressure and heart rate) were evaluated before and after transfusion. For analysis of transfusion feasibility, catheter removal after transfusion and the reason for removal were recorded. RESULTS A total of 648 transfusions were applied in 110 ELBW infants. 27 infants (24%) received no transfusion. In 12/83 (14.5%) infants who received PRBCs, transfusions were applied using a 27 G PICC line (38/648, 5.9%). Patients who received PRBCs via the PICC line were smaller at birth (582 g [range 380-752 g] vs. 710 g [430-972 g]; 23+6 [23+1-27+6] vs. 26+0 [23+1-31+4]) and required a higher number of PRBC transfusions (n=13 vs. n=5) overall. Transfusion analysis showed an appropriate increase of blood hemoglobin levels and stable potassium levels as well as cardiovascular parameters. 4/38 of PICC lines were removed within 24 h after transfusion, one due to occlusion (15 h after transfusion). CONCLUSIONS We conclude that PRBC transfusions via 27 G PICC lines were feasible and performed without signs of hemolysis in ELBW infants. Our findings may help clinicians in the management of ELBW infants requiring transfusions if a peripheral venous access is not achievable.
Collapse
Affiliation(s)
- A Repa
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - M Mayerhofer
- Department of Laboratory Medicine, Medical University Vienna, Austria
| | - N Worel
- Department of Blood Group Serology and Transfusion Medicine, Medical University Vienna, Austria
| | - F Cardona
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - P Deindl
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - A Pollak
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - A Berger
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - N Haiden
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| |
Collapse
|
21
|
Repa A, Mayerhofer M, Cardona F, Worel N, Deindl P, Pollak A, Berger A, Haiden N. Safety of blood transfusions using 27 gauge neonatal PICC lines: an in vitro study on hemolysis. Klin Padiatr 2013; 225:379-82. [PMID: 24158888 DOI: 10.1055/s-0033-1355329] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Blood transfusions are required by the majority of extremely premature infants. Packed red blood cells (PRBCs) are usually applied via simple peripheral cannulas. In situations where no peripheral venous access is achievable, 27 Gauge (G) neonatal PICC lines - that are ideally exclusively dedicated to application of parenteral nutrition - may represent a useful alternative access for PRBC transfusions. However, transfusion via small scaled catheters may damage PRBCs and lead to hemolysis. We here evaluate whether transfusion of irradiated PRBCs via 27 G PICC lines leads to hemolysis in vitro.Experimental transfusions of gamma-irradiated PRBCs were performed at increasing velocities (2.5, 3.7, 5 ml/h; full force manual push approximating 30 ml/h) via 27 G PICC lines of 20 and 30 cm length. Parameters of hemolysis (lactate dehydrogenase, potassium and free hemoglobin) were measured from the supernatants of transfused PRBCs and the percentage of hemolysis was calculated.Potassium and lactate dehydrogenase after transfusion at increasing velocities did not differ significantly from negative controls. Free hemoglobin levels showed a small but significant increase at the slowest transfusion speed (2.5 ml/h) using the 30 cm 27 G PICC line, with a relative hemolysis of only 0.13%. A manual push (approximating 30 ml/h) showed no significant changes of parameters from baseline.We conclude that transfusion of gamma-irradiated PRBCs using a 27 G neonatal PICC line does not cause clinically relevant hemolysis in vitro. Clinical studies are needed to confirm the feasibility and safety of the approach in vivo.
Collapse
Affiliation(s)
- A Repa
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - M Mayerhofer
- Department of Laboratory Medicine, Medical University Vienna, Austria
| | - F Cardona
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - N Worel
- Department of Blood Group Serology and Transfusion Medicine, Medical University Vienna, Austria
| | - P Deindl
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - A Pollak
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - A Berger
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| | - N Haiden
- Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University Vienna, Austria
| |
Collapse
|
22
|
Clemente-Postigo M, Queipo-Ortuño MI, Murri M, Boto-Ordoñez M, Perez-Martinez P, Andres-Lacueva C, Cardona F, Tinahones FJ. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res 2012; 53:973-978. [PMID: 22394503 DOI: 10.1194/jlr.p020909] [Citation(s) in RCA: 94] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
The low-grade inflammation observed in obesity has been associated with a high-fat diet, though this relation is not fully understood. Bacterial endotoxin, produced by gut microbiota, may be the linking factor. However, this has not been confirmed in obese patients. To study the relationship between a high-fat diet and bacterial endotoxin, we analyzed postprandial endotoxemia in morbidly obese patients after a fat overload. The endotoxin levels were determined in serum and the chylomicron fraction at baseline and 3 h after a fat overload in 40 morbidly obese patients and their levels related with the degree of insulin resistance and postprandial hypertriglyceridemia. The morbidly obese patients with the highest postprandial hypertriglyceridemia showed a significant increase in lipopolysaccharide (LPS) levels in serum and the chylomicron fraction after the fat overload. Postprandial chylomicron LPS levels correlated positively with the difference between postprandial triglycerides and baseline triglycerides. There were no significant correlations between C-reactive protein (CRP) and LPS levels. The main variables contributing to serum LPS levels after fat overload were baseline and postprandial triglyceride levels but not glucose or insulin resistance. Additionally, superoxide dismutase activity decreased significantly after the fat overload. Postprandial LPS increase after a fat overload is related to postprandial hypertriglyceridemia but not to degree of insulin resistance in morbidly obese patients.
Collapse
Affiliation(s)
- M Clemente-Postigo
- Laboratorio de Investigación Biomédica, Hospital Universitario Virgen de la Victoria, Spain
| | - M I Queipo-Ortuño
- Laboratorio de Investigación Biomédica, Hospital Universitario Virgen de la Victoria, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain
| | - M Murri
- Laboratorio de Investigación Biomédica, Hospital Universitario Virgen de la Victoria, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain
| | - M Boto-Ordoñez
- Department of Nutrition and Food Science, XaRTA, INSA, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain
| | - P Perez-Martinez
- CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain; Lipid and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain
| | - C Andres-Lacueva
- Department of Nutrition and Food Science, XaRTA, INSA, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain
| | - F Cardona
- Laboratorio de Investigación Biomédica, Hospital Universitario Virgen de la Victoria, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain.
| | - F J Tinahones
- CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain; Fundación IMABIS, and Servicio de Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, Spain
| |
Collapse
|
23
|
Clemente-Postigo M, Tinahones F, Cardona F. 162 ADIPOSE TISSUE GENE EXPRESSION OF FACTORS RELATED TO LIPID PROCESSING IN OBESITY. ATHEROSCLEROSIS SUPP 2011. [DOI: 10.1016/s1567-5688(11)70163-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Clemente-Postigo M, Queipo-Ortuño M, Valdivielso P, Tinahones F, Cardona F. Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients. Clin Biochem 2010; 43:1300-4. [DOI: 10.1016/j.clinbiochem.2010.08.014] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2010] [Revised: 07/14/2010] [Accepted: 08/08/2010] [Indexed: 10/19/2022]
|
25
|
Cardona F, Bagán JV, Sáinz E, Figuerido J, Giner F, Vidán FJ. [Bisphosphonate-related osteonecrosis of the jaws. An update]. An Sist Sanit Navar 2010; 32:413-21. [PMID: 20094102 DOI: 10.23938/assn.0138] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Bisphosphonates are widely used drugs, primarily for osteoporosis and also in oncology. A drug-induced side effect or complication, which only recently came to light in 2003, is osteonecrosis of the jaw. This study reviews the chemical characteristics of the various bisphosphonates, their possible mechanism of action, relative potency, the commercial products available on the spanish pharmaceutical market and the indications for bisphosphonate treatment. The study also considers osteonecrosis of the jaw with regard to its onset, concept, clinical stages, why this pathology affects the jaws, its risk factors, incidence, the attitude to be adopted by dentists with patients taking bisphosphonates, a quick review of the treatment and the possible prediction of osteonecrosis.
Collapse
Affiliation(s)
- F Cardona
- Sección de Salud Bucodental, Centro Conde Oliveto, Pamplona, Spain.
| | | | | | | | | | | |
Collapse
|
26
|
Rona Z, Klebermass K, Cardona F, Czaba CD, Brugger PC, Weninger M, Pollak A, Prayer D. Comparison of neonatal MRI examinations with and without an MR-compatible incubator: advantages in examination feasibility and clinical decision-making. Eur J Paediatr Neurol 2010; 14:410-7. [PMID: 20471292 DOI: 10.1016/j.ejpn.2010.03.005] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/02/2008] [Revised: 03/02/2010] [Accepted: 03/19/2010] [Indexed: 11/19/2022]
Abstract
PURPOSE To assess the utility of an MRI-compatible incubator (INC) by comparing. METHODS In a retrospective study, the clinical and radiological aspects of 129 neonatal MRI examinations during a 3 year period were analyzed. Routine protocols including fast spin-echo T2-weighted (w) sequences, axial T1w, Gradient-echo, diffusion sequences, and 3D T1 gradient-echo sequences were performed routinely, angiography and spectroscopy were added in some cases. Diffusion-tensor imaging was done in 50% of the babies examined in the INC and 26% without INC. Sequences, adapted from fetal MR-protocols were done in infants younger than 32 gestational weeks. Benefit from MR-information with respect to further management was evaluated. RESULTS The number of the examinations increased (30-99), while the mean age (43-38, 8 weeks of gestational age) and weight (3308-2766 g) decreased significantly with the use of the MR-compatible incubator. The mean imaging time (34, 43-30, 29 min) decreased, with a mean of one additionally performed sequence in the INC group. All infants received sedatives according to our anaesthetic protocol preceding imaging, but a repeated dose was never necessary (10% without INC) using the INC. Regarding all cases, MR-based changes in clinical management were initiated in 58%, while in 57% of cases the initial ultrasound diagnosis was changed or further specified. CONCLUSIONS The use of the INC enables the MR access of unstable infants with suspect CNS problems to the management, of whom is improved by MR information to significantly higher percentage, than without INC.
Collapse
Affiliation(s)
- Z Rona
- Neonatal Intensive Care Unit, 1st Department of Obstetrics and Gynaecology, Semmelweis University, Budapest, Hungary.
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Forcella M, Cardona F, Goti A, Parmeggiani C, Cipolla L, Gregori M, Schirone R, Fusi P, Parenti P. A membrane-bound trehalase from Chironomus riparius larvae: purification and sensitivity to inhibition. Glycobiology 2010; 20:1186-95. [DOI: 10.1093/glycob/cwq087] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
|
28
|
Clemente-Postigo M, Queipo-Ortuño M, Tinahones F, Cardona F. P341 EFFECT OF APOCIII SSTI POLYMORPHISM IN POSTPRANDIAL RESPONSE TO A FAT OVERLOAD IN METABOLIC SYNDROME PATIENTS. ATHEROSCLEROSIS SUPP 2010. [DOI: 10.1016/s1567-5688(10)70408-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
29
|
Murri M, Garcia-Delgado R, Alcázar-Ramirez J, Linde F, Fernández-Ramos A, Cardona F, Tinahones FJ. Assessment of cellular and plasma oxidative stress in SAHS patients before and after continuous positive airway pressure treatment. Clin Lab 2010; 56:397-406. [PMID: 21086785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND Several indirect techniques have been used for measuring oxidative stress in sleep apnoea-hypopnoea syndrome (SAHS) patients. The purpose of this study was to find out if both, cellular or plasma oxidative stress evaluations, are good estimators to assess oxidative stress in SAHS patients before and after one month's CPAP treatment. METHODS The study included 28 SAHS patients requiring CPAP treatment and 15 healthy control subjects. Plasma and serum oxidative stress biomarkers (lipid peroxidation, total antioxidant capacity, and the activities of glutathione peroxidase, glutathione reductase, glutathione s-transferase, catalase and superoxide dismutase) were measured using commercial kits. Cellular oxidative stress biomarkers (mitochondrial membrane potential, intracellular glutathione, superoxide anion, and hydrogen peroxide) were analysed by flow cytometry. The Wilcoxon test for paired samples was used to compare oxidative stress and clinical parameters in patients before and after treatment with CPAP. Relationships in oxidative stress markers between controls and patients were analyzed using the Mann-Whitney U test. The Spearman correlation coefficient was calculated to estimate the linear correlations between variables. RESULTS Oxidative stress was notably decreased after CPAP. Before CPAP, SAHS severity positively correlated with hydrogen peroxide levels, while negative correlations were observed between SAHS severity and plasma TAC in patients. Also, plasma glutathione peroxidase activity negatively correlated with cellular superoxide anion, while plasma superoxide dismutase activity positively correlated with intracellular glutathione. After CPAP, plasma TAC and glutathione peroxidase activity negatively correlated with cellular hydrogen peroxide and superoxide anion. CONCLUSIONS In conclusion, this study seems to confirm that plasma and cellular assessment reflect, in the same way, the oxidative stress status of the studied patients. Furthermore, plasma total antioxidant capacity as well as cellular hydrogen peroxide levels can be good markers for assessing oxidative stress in SAHS patients.
Collapse
Affiliation(s)
- M Murri
- Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, 29010 Málaga, Spain.
| | | | | | | | | | | | | |
Collapse
|
30
|
Cardona F, Bagán J, Sáinz E, Figuerido J, Giner F, Vidán F. Osteonecrosis de los maxilares por bisfosfonatos: Actualización y puesta al día. An Sist Sanit Navar 2009. [DOI: 10.4321/s1137-66272009000500012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
31
|
Garrido-Sánchez L, García-Fuentes E, Cardona F, Rojo-Martínez G, Soriguer F, Tinahones FJ. Anti-oxidized LDL antibody levels are reduced in women with hypertension. Eur J Clin Invest 2009; 39:800-6. [PMID: 19674079 DOI: 10.1111/j.1365-2362.2009.02156.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
BACKGROUND Previous studies have suggested that hypertension may be associated with increased oxidized low-density lipoprotein (LDL). Increased in vitro oxidizability of LDL or elevated titers of anti-oxidized LDL antibodies have been shown in subjects with essential hypertension. However, the relationship between oxidized LDL and hypertension is equivocal. We examined the association between hypertension and levels of IgG anti-oxidized LDL antibodies in a group of women from the general population. MATERIALS AND METHODS The study included 619 women classified according to their blood pressure values. IgG anti-oxidized LDL antibodies were measured by enzyme-linked immunosorbent assay and the women were classified as being above or below the 50th percentile. RESULTS Hypertension was present in 54.3% of the women. These women had significantly lower levels of IgG anti-oxidized LDL antibodies than the normotensive women (0.280 +/- 0.117 vs. 0.336 +/- 0.125, P < 0.001). Both systolic and the diastolic blood pressures showed a significant negative correlation with the levels of IgG anti-oxidized LDL antibodies (r = -0.204, P < 0.001; r = -0.225, P < 0.001, respectively). Women with IgG anti-oxidized LDL antibody levels above the 50th percentile had a lower prevalence of hypertension than those with IgG anti-oxidized LDL antibody levels below the 50th percentile (40.2% vs. 59.8%) (P < 0.001). CONCLUSIONS Women with hypertension had lower levels of IgG anti-oxidized LDL antibodies than normotensive women.
Collapse
Affiliation(s)
- L Garrido-Sánchez
- CIBER Fisiopatología de la Obesidad y Nutrición (CB06/03), ISCIII, Madrid, Spain.
| | | | | | | | | | | |
Collapse
|
32
|
Cardona F, Queipo-Ortuño MI, Murri M, Tinahones F. Abstract: P923 OXIDATIVE STRESS AFTER FAT OVERLOAD IN PERSONS WITH BASELINE HYPERTRIGLYCERIDEMIA WITH OR WITHOUT THE METABOLIC SYNDROME. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)71044-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
33
|
Czaba CD, Rona Z, Klebermaß K, Cardona F, Weninger M, Pollak A. Development of sleep-wake cycles in the premature infant – a case study. Z Geburtshilfe Neonatol 2009. [DOI: 10.1055/s-0029-1223166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
34
|
Cardona F, Aranda A, del Olmo M. Ubiquitin ligase Rsp5p is involved in the gene expression changes during nutrient limitation in Saccharomyces cerevisiae. Yeast 2009; 26:1-15. [PMID: 19180642 DOI: 10.1002/yea.1645] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Rsp5p is an essential ubiquitin ligase involved in many different cellular events, including amino acid transporters degradation, transcription initiation and mRNA export. It plays important role in both stress resistance and adaptation to the change of nutrients. We have found that ubiquitination machinery is necessary for the correct induction of the stress response SPI1 gene at the entry of the stationary phase. SPI1 is a gene whose expression is regulated by the nutritional status of the cell and whose deletion causes hypersensitivity to various stresses, such as heat shock, alkaline stress and oxidative stress. Its regulation is mastered by Rsp5p, as mutations in this gene lead to a lower SPI1 expression. In this process, Rsp5p is helped by several proteins, such as Rsp5p-interacting proteins Bul1p/2p, the ubiquitin conjugating protein Ubc1p and ubiquitin proteases Ubp4p and Ubp16p. Moreover, a mutation in the RSP5 gene has a global effect at the gene expression level when cells enter the stationary phase. Rsp5p particularly controls the levels of the ribosomal proteins mRNAs at this stage. Rsp5p is also necessary for a correct induction of p-bodies under stress conditions, indicating that this protein plays an important role in the post-transcriptional fate of mRNA under nutrient starvation.
Collapse
Affiliation(s)
- F Cardona
- Department of Biochemistry and Molecular Biology, University of Valencia, Spain
| | | | | |
Collapse
|
35
|
Tinahones FJ, Rubio MA, Garrido-Sánchez L, Ruiz C, Gordillo E, Cabrerizo L, Cardona F. Green tea reduces LDL oxidability and improves vascular function. J Am Coll Nutr 2008; 27:209-13. [PMID: 18689551 DOI: 10.1080/07315724.2008.10719692] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
OBJECTIVE Several different epidemiological studies have examined the association between the consumption of tea and coronary heart disease. Some, though not all, support the view that tea or flavonoids reduce the risk of cardiovascular heart disease. The aim of this study was to determine the short-to medium-term effect of a green tea extract on vascular function and lipid peroxidation as compared with placebo. METHODS The study was undertaken with 14 healthy women, none of whom were receiving any medical treatment. Measurements were made of antibodies and immune complexes by ELISA, endothelial dependent vascular function by Doppler ultrasound, and the concentration of oxidized LDL by TBARS. RESULTS The mean diameter of the brachial artery following the post-compression hyperaemia phase rose significantly (p < 0.0001) after treatment with green tea extract. Flow-mediated brachial artery vasodilation ranged from 5.68% for the placebo phase to 11.98% after the green tea extract (p = 0.02). The consumption of green tea extract was associated with a significant 37.4% reduction in the concentration of oxidized LDL (TBARS) (p = 0.017). The levels of anti-oxidized LDL IgM antibodies fell significantly after treatment (p = 0.002). CONCLUSION This study found that consumption of green tea extract by women for five weeks produced modifications in vascular function and an important decrease in serum oxidizability.
Collapse
Affiliation(s)
- F J Tinahones
- Servicio de Endocrinología, Hospital Clinico Virgen de la Victoria de Málaga, Spain.
| | | | | | | | | | | | | |
Collapse
|
36
|
Garrido-Sánchez L, Cardona F, García-Fuentes E, Rojo-Martínez G, Gómez-Zumaquero JM, Picón MJ, Soriguer F, Tinahones FJ. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus. Eur J Clin Invest 2008; 38:615-21. [PMID: 18837736 DOI: 10.1111/j.1365-2362.2008.01988.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND Anti-oxidized low-density lipoprotein (LDL) antibodies are associated with the oxidative capacity of plasma, but whether they protect or promote diabetes is unknown. We undertook a prospective study to determine the predictive capacity of anti-oxidized LDL antibodies for the onset of type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS We selected 391 non-diabetic women aged 18-65 years. The subjects were classified as being normal (oral glucose test tolerance normal, OGTT-N), or having impaired glucose tolerance (IGT), impaired fasting glucose (IFG) or T2DM according to their baseline glucose levels and after an OGTT. The same subjects were studied six years later. The levels of anti-oxidized LDL antibodies were classified as above or below the 50th percentile. RESULTS Of the women who were OGTT-N at the start of the study and who had anti-oxidized LDL antibody levels below the 50th percentile, only 65.1% were still OGTT-N after 6 years versus 79.5% of those who had anti-oxidized LDL antibody levels above the 50th percentile (P = 0.015). Women who had IGT or IFG at the start of the study whose anti-oxidized LDL antibody levels were below the 50th percentile had a relative risk of 9.79 (95% confidence interval, 1.40-68.45) of developing diabetes (P < 0.001). Logistic regression analysis showed that the variables predicting the development of a carbohydrate metabolism disorder in the women after 6 years were body mass index (P < 0.001) and the levels of anti-oxidized LDL antibodies (P = 0.042). CONCLUSIONS Levels of anti-oxidized LDL antibodies are independent predictors for the development of T2DM in women.
Collapse
Affiliation(s)
- L Garrido-Sánchez
- Endocrinology and Nutrition Service, Virgen de la Victoria Clinical Hospital, Malaga, Spain
| | | | | | | | | | | | | | | |
Collapse
|
37
|
Abstract
BACKGROUND Patients with the metabolic syndrome have greater levels of oxidative stress. However, as the response of markers of this stress to a fat overload is unknown, we evaluated certain markers of oxidative stress in these patients. MATERIAL AND METHODS The study population comprised 93 subjects (70 men and 23 women): 13 healthy people (controls) with a mean age of 48.81 +/- 9.01 years and 80 patients with the metabolic syndrome (mean age, 43.25 +/- 11.55 years), according to the Adult Treatment Panel III criteria. All the participants were given a 60 g fat overload (Supracal). Three hours later the following biomarkers of oxidative stress were measured: lipid peroxidation products, protein carbonyl groups, reduced glutathione, glutathione peroxidase (GSH-Px), catalase, superoxide dismutase, glutathione reductase (GSH-Road) and glutathione S-transferase. The levels of oxidized glutathione (GSSG) were calculated. RESULTS Compared with the controls, the patients showed greater baseline oxidative stress, higher levels of lipid peroxidation products and oxidized glutathione, and lower levels of reduced glutathione, glutathione peroxidase activity, glutathione reductase and glutathione transferase. This stress was more intense after the subjects received a fat overload, more so in the patients who experienced a greater reduction in GSHpx and GSHrd antioxidant activity and a greater increase in the levels of carbonylated proteins and lipoperoxides than the controls. CONCLUSIONS Patients with the metabolic syndrome have greater oxidative stress than healthy people. The variation in markers of this stress after a fat overload was even more pronounced in the patients.
Collapse
Affiliation(s)
- F Cardona
- Endocrinology and Nutrition Service, Virgen de la Victoria University Hospital, 29010 Malaga, Spain.
| | | | | | | | | | | |
Collapse
|
38
|
Cardona F, Tunez I, Tasset I, Murri M, Tinahones F. Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome. Clin Biochem 2008; 41:701-5. [DOI: 10.1016/j.clinbiochem.2008.03.001] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2007] [Revised: 02/21/2008] [Accepted: 03/01/2008] [Indexed: 01/28/2023]
|
39
|
Klebermasz K, Rona Z, Cardona F, Brugger P, Pollak A, Weninger M, Prayer D. Vergleich von Schädel-MRT-Untersuchungen im Patientenkollektiv einer neonatologischen Intensivstation mit und ohne Einsatz eines MR-kompatiblen Inkubators. Z Geburtshilfe Neonatol 2008. [DOI: 10.1055/s-2008-1079054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
40
|
Cardona F, Klebermass K, Rona Z, Bodamer O, Weninger M, Pollak A. Einsatz desamplituden-integrierten EEG zur kontinuierlichen neurologischen Überwachung eines Patienten mit metabolischer Enzephalopathie im Rahmen einer Propionazidämie. Z Geburtshilfe Neonatol 2008. [DOI: 10.1055/s-2008-1079046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
41
|
Morales-Nin B, Geffen AJ, Cardona F, Kruber C, Saborido-Rey F. The effect of Prestige oil ingestion on the growth and chemical composition of turbot otoliths. Mar Pollut Bull 2007; 54:1732-41. [PMID: 17889035 DOI: 10.1016/j.marpolbul.2007.07.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/27/2007] [Revised: 07/09/2007] [Accepted: 07/16/2007] [Indexed: 05/17/2023]
Abstract
Juvenile turbot (Scophthalmus maximus) were kept in captivity and were fed a prepared food contaminated with five different concentrations of seawater-accommodated fuel oil from 2.4+/-0.35 to 48.2+/-2.2 mg g(-1) food, with a control group receiving uncontaminated food. The growth and survival of individually tagged fish (N=202) were measured after a six-week treatment period. The otolith growth rate was measured and otolith composition was determined before and after the treatments using LA-ICPMS. Fish and otolith growth were negatively affected by the fuel oil treatment, and the response decreased with the level of contamination. Otolith growth and element incorporation peaked at mid level exposures and decreased at the highest level. The otolith elemental composition reflected the presence of some elements in the Prestige fuel that may have been incorporated through the diet into the otolith.
Collapse
Affiliation(s)
- B Morales-Nin
- Instituto Mediterráneo de Estudios Avanzados (CSIC/UIB), Miquel Marqués 21, 07190 Esporles, Illes Balears, Spain.
| | | | | | | | | |
Collapse
|
42
|
Tinahones FJ, Cardona F, Rojo-Martínez G, Almaraz MC, Cardona I, Vázquez-Mellado J, Garrido-Sánchez L, Collantes E, Soriguer F. Decreased levels of uric acid after oral glucose challenge is associated with triacylglycerol levels and degree of insulin resistance. Br J Nutr 2007; 99:44-8. [PMID: 17761018 DOI: 10.1017/s0007114507787470] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Hyperuricaemia is one of the components of metabolic syndrome. Both oxidative stress and hyperinsulinism are important variables in the genesis of this syndrome and have a close association with uric acid (UA). We evaluated the effect of an oral glucose challenge on UA concentrations. The study included 656 persons aged 18 to 65 years. Glycaemia, insulin, UA and plasma proteins were measured at baseline and 120 min after an oral glucose tolerance test (OGTT). The baseline sample also included measurements of total cholesterol, triacylglycerol (TAG) and HDL-cholesterol. Insulin resistance was calculated with the homeostasis model assessment. UA levels were significantly lower after the OGTT (281·93 (sd92·19)v. 267·48 (sd90·40) μmol/l;P < 0·0001). Subjects with a drop in UA concentrations >40·86 μmol/l (>75th percentile) had higher plasma TAG levels (P = 0·0001), baseline insulin (P = 0·02) and greater insulin resistance (P = 0·034). Women with a difference in plasma concentrations of UA above the 75th percentile had higher baseline insulin levels (P = 0·019), concentration of plasma TAG (P = 0·0001) and a greater insulin resistance index (P = 0·029), whereas the only significant difference in men was the level of TAG. Multiple regression analysis showed that the basal TAG levels, insulin at 120 min, glycaemia at 120 min and waist:hip ratio significantly predicted the variance in the UA difference (r20·077). Levels of UA were significantly lower after the OGTT and the individuals with the greatest decrease in UA levels are those who have greater insulin resistance and higher TAG levels.
Collapse
Affiliation(s)
- F J Tinahones
- Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga and CIBER Fisiopatología de la obesidad y nutrición CB06/03 Instituto de Salud Carlos III, Málaga, Spain.
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Garcia-Almeida J, Cardona F, Rojo-Martinez R, Morcillo S, Cardona I, Esteva I, Murri M, Almaraz M, Soriguer F, Tinahones F. YI-823 URIC ACID PREDICTS DIABETES IN THE GENERAL POPULATION. ATHEROSCLEROSIS SUPP 2007. [DOI: 10.1016/s1567-5688(07)71833-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
44
|
Lucha P, Cardona F, Gutiérrez F, Guerrero J. Natural and human-induced dissolution and subsidence processes in the salt outcrop of the Cardona Diapir (NE Spain). ACTA ACUST UNITED AC 2007. [DOI: 10.1007/s00254-007-0729-3] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
45
|
Gutiérrez F, Calaforra JM, Cardona F, Ortí F, Durán JJ, Garay P. Geological and environmental implications of the evaporite karst in Spain. ACTA ACUST UNITED AC 2007. [DOI: 10.1007/s00254-007-0721-y] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
46
|
Leitner JM, Jilma B, Mayr FB, Cardona F, Spiel AO, Firbas C, Rathgen K, Stähle H, Schühly U, Graefe-Mody EU. Pharmacokinetics and Pharmacodynamics of the Dual FII/FX Inhibitor BIBT 986 in Endotoxin-induced Coagulation. Clin Pharmacol Ther 2007; 81:858-66. [PMID: 17410124 DOI: 10.1038/sj.clpt.6100153] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BIBT986 is a dual inhibitor of factors Xa and IIa. The aim of this study was to compare with placebo the effect of three doses of BIBT986 on coagulation, platelet activation, and inflammation. This was a prospective, randomized, double-blind, placebo-controlled, parallel-group dose escalation trial in 48 healthy male volunteers. Participants received one of three doses of BIBT986 or placebo intravenously together with a bolus infusion of 2 ng/kg lipopolysaccharide (LPS). BIBT986 dose-dependently changed global coagulation parameters and in vivo markers of thrombin generation and action: BIBT986 doses, which prolonged activated partial thromboplastin time by 100%, completely suppressed the LPS-induced increases in prothrombin fragment, thrombin-antithrombin complexes, and D-dimer, which were 6.1-, 14.5, and 3.5-fold in the placebo group, respectively. BIBT986 did not influence inflammation, fibrinolysis, or platelet activation. Therefore, BIBT986 is a potent anticoagulant in the human endotoxemia model.
Collapse
Affiliation(s)
- J M Leitner
- Department of Clinical Pharmacology, Division of Haematology & Immunology, Medical University of Vienna, Vienna, Austria
| | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Soriguer F, Moreno F, Rojo-Martínez G, García-Fuentes E, Tinahones F, Gómez-Zumaquero JM, Cuesta-Muñoz AL, Cardona F, Morcillo S. Monounsaturatedn-9 fatty acids and adipocyte lipolysis in rats. Br J Nutr 2007; 90:1015-22. [PMID: 14641960 DOI: 10.1079/bjn2003993] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
To investigate the role of the monounsaturatedn-9 fatty acids (MUFA) in the lipolytic activity of adipocytes, a study was carried out in which an increase in MUFA was produced in the tissues by two different methods; by the dietary enrichment of oleic acid or by producing an essential fatty acid deficiency syndrome. For this, forty-five male Sprague–Dawley rats were fed with a normal-energy diet and were subdivided into three groups. The diets varied in the type of dietary fat; palmitic acid, olive oil, or soyabean oil+palmitic acid. At the end of the study measurements were taken of weight, plasma leptin, tissue concentration of fatty acids, fat-cell size in the epididymal and the omental adipose tissues, adipocyte lipolytic activity of both tissues after stimulation with adrenaline, and the capacity of insulin to inhibit lipolysis. The baseline and adrenaline-stimulated lipolytic activity were greater and the anti-lipolytic capacity of insulin lower in the animals undergoing an increase in MUFA in the tissues (palmitic-acid and olive-oil diets). The area under the curve of glycerol, used as an indicator of lipolytic activity, was positively correlated with the concentration of MUFA and negatively with polyunsaturated fatty acids in the adipose tissues. It is concluded that an increase in tissue MUFA, however obtained, induces an increase in lipolytic activity.
Collapse
Affiliation(s)
- F Soriguer
- Endocrinology and Nutrition Service, Carlos Haya Hospital Complex, Malaga-29009, Spain.
| | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Haus-Cheymol R, Burlation G, Berger F, Wendling G, Schwartzbrod PE, Cardona F, Terrier F, Spiegel A. [Clustered cases of urinary and intestinal bilharziasis in French military personnel]. Med Trop (Mars) 2007; 67:98-9. [PMID: 17506283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
|
49
|
|
50
|
Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, Jilma B, Pollak A. A randomized controlled trial on the effects of adding vitamin B 12 and folate. Z Geburtshilfe Neonatol 2006. [DOI: 10.1055/s-2006-946031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|